Has Rita Gelsomini Gruber, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,271 in general payments to Rita Gelsomini Gruber, MD across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rita Gelsomini Gruber, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rita Gelsomini Gruber, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rita Gelsomini Gruber, MD

Child & Adolescent Psychiatry · Portsmouth, NHNPI 1770659831

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 26.0% of the total. 2025 is the largest year on record at $1,220, 6.3 times the $194 reported in 2023.

$2,271in general payments, 2019–2025

Across 132 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$591
Teva Pharmaceuticals USA, Inc.$305
AbbVie$304
Lundbeck LLC$296
Johnson & Johnson$230
Axsome Therapeutics, Inc.$214
plus $331 from 7 others

What the payments were for

Food & beverage$2,271100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	22	$591
Teva Pharmaceuticals USA, Inc.	22	$305
AbbVie	18	$304
Lundbeck LLC	22	$296
Johnson & Johnson	14	$230
Axsome Therapeutics, Inc.	16	$214
Takeda Pharmaceuticals U.S.A., Inc.	9	$171
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$39
Neurocrine Biosciences, Inc.	2	$37
Corium, LLC	2	$37
Ironshore Pharmaceuticals Inc.	1	$18
Idorsia Pharmaceuticals US Inc	1	$14
Alkermes, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

QELBREE$168

How this compares

Too few child & adolescent psychiatry providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$16,942

Medicare patients

Services billed

197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Olanzapine	19	$175

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Portsmouth

Ilene SpitzerPortsmouth$249
Craig DonnellyLebanon$8K
Sreenivas KatragaddaManchester$5K
Arun KrishnanNashua$3K
Allan MendellNashua$2K
Robert KaladishAmherst$410
Walter WingateManchester$309
Ellen SchleferRochester$186
James McGovernHampstead$113
Rejini ThomasLebanon$83

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →